ConductScience.org, home

Paper36949472

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis.

Schultz A and 13 others. Trials, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis. Papers, record 36949472. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949472

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis.
PubMed
Journal
Trials
PubMed
Year
2023
PubMed
Publication types
Clinical Trial Protocol, Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2025-01-30
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schultz AAndre
2McLeod CCharliehttps://orcid.org/0000-0002-3197-7493
3Berry SScott
4Marsh JJulie
5McKenzie AAnne
6Messer MMitch
7Wood JJamie
8Saville BBen
9Jaffe AAdam
10Ranganathan SSarath
11Stick SSteve
12Wark PPeter
13Webb SSteve
14Snelling TTom

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Adult
Child
Humans
Anti-Bacterial Agents
Bayes Theorem
Forced Expiratory Volume
Lung
Prospective Studies
Quality of Life
Multicenter Studies as Topic
Adaptive Clinical Trials as Topic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GNT1152376MRFFPubMed

Source PubMed

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128778919The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.Thorax2018https://conductscience.org/library/papers/28778919PubMed
231483853Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31483853PubMed
316608383Getting it right: being smarter about clinical trials.PLoS Med2006https://conductscience.org/library/papers/16608383PubMed
425911223Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.Thorax2016https://conductscience.org/library/papers/25911223PubMed
530376155Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30376155PubMed
628679092Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.N Engl J Med2017https://conductscience.org/library/papers/28679092PubMed
734266854Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians.BMJ Open Respir Res2021https://conductscience.org/library/papers/34266854PubMed
827440100SPIRIT 2013 Statement: defining standard protocol items for clinical trials.Rev Panam Salud Publica2015https://conductscience.org/library/papers/27440100PubMed
928460885Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.J Cyst Fibros2017https://conductscience.org/library/papers/28460885PubMed
1032571382Defining key design elements of registry-based randomised controlled trials: a scoping review.Trials2020https://conductscience.org/library/papers/32571382PubMed
1128438499Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.J Cyst Fibros2017https://conductscience.org/library/papers/28438499PubMed
1224315208Lung clearance index: evidence for use in clinical trials in cystic fibrosis.J Cyst Fibros2014https://conductscience.org/library/papers/24315208PubMed
1326595740Pulmonary Exacerbations in Children with Cystic Fibrosis.Ann Am Thorac Soc2015https://conductscience.org/library/papers/26595740PubMed
1423734646Novel end points for clinical trials in young children with cystic fibrosis.Expert Rev Respir Med2013https://conductscience.org/library/papers/23734646PubMed
1518090999Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors.Epidemiology2008https://conductscience.org/library/papers/18090999PubMed
1619481983Patient-reported respiratory symptoms in cystic fibrosis.J Cyst Fibros2009https://conductscience.org/library/papers/19481983PubMed
1734469706A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.Am J Respir Crit Care Med2021https://conductscience.org/library/papers/34469706PubMed
1832800708Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment.J Cyst Fibros2021https://conductscience.org/library/papers/32800708PubMed
1910190914Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.J Pediatr1999https://conductscience.org/library/papers/10190914PubMed
2031462747Adaptive platform trials: definition, design, conduct and reporting considerations.Nat Rev Drug Discov2019https://conductscience.org/library/papers/31462747PubMed

See all 28 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn Papers
39831540Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/39831540

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RAB40B10966PubTator's text mininghttps://conductscience.org/library/genes/10966

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36949472

GET https://conductscience.org/api/papers/v1/36949472/references?page=2